[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349785-105":59,"doc-detail-349785-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","comprehensive-analysis-of-igfl1-in-colorectal-cancer-and-its-promotion-of-tumour-progression-via-inhibition-of-lipophagy","Comprehensive analysis of IGFL1 in colorectal cancer and its promotion of tumour progression via inhibition of lipophagy","","Colorectal cancer remains a leading cause of cancer-related mortality, while insulin growth factor like family member 1 (IGFL1) has been implicated in diverse diseases but lacks clear functional characterization in CRC. This study integrates TCGA and GEO bioinformatics with experimental validation to define IGFL1’s expression, diagnostic relevance, prognostic associations, and links to clinicopathological traits and immune microenvironment regulation, as well as immunotherapy and chemotherapy response.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/comprehensive-analysis-of-igfl1-in-colorectal-cancer-and-its-promotion-of-tumour-progression-via-inhibition-of-lipophagy/349785/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/comprehensive-analysis-of-igfl1-in-colorectal-cancer-and-its-promotion-of-tumour-progression-via-inhibition-of-lipophagy/349785.png","ImageObject",300,407,{"name":92,"@type":93},"Ivy","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main aim of this study on IGFL1 in colorectal cancer?","Question",{"text":112,"@type":113},"To clarify how IGFL1 is involved in colorectal cancer using integrated bioinformatics analysis and experimental validation.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How is IGFL1 expression evaluated and validated?",{"text":117,"@type":113},"IGFL1 expression is assessed using TCGA and GEO datasets, and immunohistochemistry is performed to validate IGFL1 protein levels in CRC tissues.",{"name":119,"@type":110,"acceptedAnswer":120},"What key biological mechanism does the study link to IGFL1?",{"text":121,"@type":113},"Inhibition of IGFL1 enhances lipophagy, and the results support that IGFL1 promotes CRC progression by suppressing lipophagy.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349785,1790939334,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},549758252649,"https://ap-avatar.wpscdn.com/avatar/8000253669c5317157?_k=1778319167496531819","TYPE Original Research PUBLISHED 19 January 2026  \nDOI 10.3389/fimmu.2025.1719525  \nOPEN ACCESS  \nEDITED BY  \nTianyu Cao,  \nAir Force Medical University, China  \nREVIEWED BY  \nZe Xiang,  \nZhejiang University, China Yihang Yuan,  \nShanghai Jiao Tong University, China Hengxing Chen,  \nSun Yat-sen University, China  \n*CORRESPONDENCE  \nDan Jiang  \n [danjiang@scu.edu.cn](danjiang@scu.edu.cn)  \nRECEIVED 06 October 2025  \nREVISED 21 December 2025  \nACCEPTED 29 December 2025  \nPUBLISHED 19 January 2026  \nCITATION  \nWang A, Zhou Y, Deng Z, Duan Y, Dai Zand Jiang D (2026) Comprehensive analysis of IGFL1 in colorectal cancer and its promotion of tumour progression via inhibition of lipophagy.  \nFront. Immunol. 16:1719525 .  \ndoi: 10.3389/fimmu.2025.1719525  \nCOPYRIGHT  \n© 2026 Wang, Zhou, Deng, Duan, Dai and Jiang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nComprehensive analysis of IGFL1 in colorectal cancer and its promotion of tumour progression via inhibition of lipophagy  \nAo Wang 1,2, Yu Zhou 1, Zhijuan Deng 1, Ying Duan 1, Zhenjie Dai 1 and Dan Jiang 1*  \n1 Department of Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan, China, 2 Department of Pathology, Afﬁliated Hospital of Panzhihua University, Panzhihua, Sichuan, China  \nObjective: Colorectal cancer (CRC) ranks among the most prevalent malignancies, with increasing incidence and mortality rates presenting a substantial public health challenge. While insulin growth factor like family member 1 (IGFL1) has been implicated in the regulation of various diseases, its functional role in colorectal cancer remains poorly characterised. This study therefore aims to elucidate the involvement of IGFL1 in CRC through an integrated approach combining bioinformatics analysis and experimental validation.  \nMethods: The expression of IGFL1 in CRC and its association with clinicopathological features, diagnostic relevance, and patient prognosis were evaluated using data from The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases. Immunohistochemistry was performed to validate IGFL1 protein expression in CRC tissue samples. Immune cell inﬁltration levels and immune microenvironment scores related to IGFL1 expression were analysed using multiple computational algorithms, including CIBERSORT, ssGSEA, ESTIMATE, EPIC, MCP-counter, quanTIseq, TIMER, xCell, and CIBERSOR. Furthermore, IGFL1 expression patterns across distinct cellular subpopulations were examined using single-cell RNA sequencing datasets from the Tumor Immune Single-cell Hub (TISCH) database. The TIDE algorithm was applied to assess the potential clinical efﬁcacy of immunotherapy in groups with high versus low IGFL1 expression, in addition to investigating correlations between IGFL1 expression and immune checkpoint markers. Genetic alterations of IGFL1 were analysed via cBioPortal, while the TIMER2.0 database was used to explore relationships between IGFL1 expression and key gene mutations in CRC. The CTRP and GDSC databases were employed to investigate associations between IGFL1 expression and sensitivity to conventional chemotherapy drugs. Finally, phenotypic validation and mechanistic studies were conducted using the CRC cell lines SW620 and HCT116 .  \nResults: Our study demonstrates that IGFL1 expression is signiﬁcantly upregulated in CRC and possesses considerable diagnostic value. Elevated IGFL1 levels were consistently observed in clinical specimens, where high expression correlated with adverse clinicopathological features, poorer prognosis, and mutations in key oncogenes. Within the tumo","cbCaioFtuVAItSgt","https://ap.wps.com/l/cbCaioFtuVAItSgt","pdf",6705989,23,"English","# Objective\n# Methods\n# Results\n# Conclusions\n# Introduction\n## Molecular context of colorectal cancer\n## IGFL proteins and rationale","[{\"question\":\"What is the main aim of this study on IGFL1 in colorectal cancer?\",\"answer\":\"To clarify how IGFL1 is involved in colorectal cancer using integrated bioinformatics analysis and experimental validation.\"},{\"question\":\"How is IGFL1 expression evaluated and validated?\",\"answer\":\"IGFL1 expression is assessed using TCGA and GEO datasets, and immunohistochemistry is performed to validate IGFL1 protein levels in CRC tissues.\"},{\"question\":\"What key biological mechanism does the study link to IGFL1?\",\"answer\":\"Inhibition of IGFL1 enhances lipophagy, and the results support that IGFL1 promotes CRC progression by suppressing lipophagy.\"}]","Comprehensive analysis of IGFL1 in colorectal cancer and its promotion of tumour progression via inhibition of lipophagy | PDF",1790085560,58,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/20a38b64a6d6cbb5df7212b4240137e2.webp",983,1389,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9f6bcbfb3dcc8e12f832b5179a0fcbc9.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/229c098744063987fd105bc33dac8520.webp",981,1386,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f52c7db6e5829b298ba6ff8a6b29d481.webp",980,1385]